Form 8-K - Current report:
SEC Accession No. 0001104659-21-102543
Filing Date
2021-08-10
Accepted
2021-08-10 08:00:41
Documents
12
Period of Report
2021-08-04
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2124650d1_8k.htm   iXBRL 8-K 33625
  Complete submission text file 0001104659-21-102543.txt   213240

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20210804.xsd EX-101.SCH 3209
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20210804_lab.xml EX-101.LAB 34593
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20210804_pre.xml EX-101.PRE 22726
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2124650d1_8k_htm.xml XML 3858
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

EIN.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 211158463
SIC: 2834 Pharmaceutical Preparations